Mogens Christensen

This inventor holds 3 USPTO granted patents. Top assignees: Novo Nordisk A/s, Noyo Nordisk A/s. Active years: 1991-1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mogens Christensen. Retrieved from https://idiyas.com/inventor/mogens-christensen-6jiaf628

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 3

% Patents Active = 100.0

Average Co-Inventor Count = 5.3

ph-index = 3

Forward Citations = 21(Granted Patents)

Location History:

Kobenhavn, DK (1991)
Copenhagen, DK (1992)
Gentofte, DK (1998)

Company Filing History:

Years Active: 1991-1998

Loading Chart...

3 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 5783416 - Human spasmolytic polypeptide in glycosylated form (1998-07-21),

2. 5175113 - Modified .beta..sub.2 -microglobulin (1992-12-29),

3. 5051371 - Modified .beta..sub.2 -microglobulin (1991-09-24),

Title: Inventor Mogens Christensen

Introduction: Mogens Christensen is a renowned inventor based in Kobenhavn, Denmark, known for his groundbreaking contributions to various fields.

Latest Patents: Mogens Christensen holds several patents in the areas of renewable energy technologies, sustainable materials, and innovative manufacturing processes.

Career Highlights: With a career spanning over three decades, Mogens Christensen has worked on numerous projects that have revolutionized industries such as clean energy, biotechnology, and telecommunications.

Collaborations: Throughout his career, Mogens Christensen has collaborated with leading research institutions, universities, and multinational corporations to bring his inventions to life and make a positive impact on society.

Conclusion: Mogens Christensen's passion for innovation and his dedication to creating solutions for the future continue to inspire the next generation of inventors and entrepreneurs.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]